Cadchem Laboratories Ltd is a leading manufacturer of Active Pharmaceutical Ingredients (APIs) established in 1995. The company is dedicated to developing and manufacturing niche APIs and their intermediates, specialising in the cardio, neuro, and anti-diabetic segments. Cadchem Laboratories holds Korean MFDS and WHO-GMP approvals, ensuring high-quality standards in its products. With a focus on the global market, the company offers products that include Clopidogrel Bisulphate Form II and Levetiracetam, alongside plans for additional APIs such as Rosuvastatin Calcium and Rifaximin.

Services include:
– Regulatory Services
– APIs (Active Pharmaceutical Ingredients)
– Intermediates
– Fine Chemicals

Cadchem Laboratories is committed to enhancing the pharmaceutical industry with its diverse range of products and services. For more information, visit cadchem.com.